Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Duloxetine HCl

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Duloxetine HCl Manufacturers in India Suppliers Duloxetine HCl Exporters Distributors Duloxetine HCl api active pharmaceuticals ingredients Duloxetine HCl manufacturers Side Effects bulk drugs raw material Duloxetine HCl companies Side Effects Importers Duloxetine HCl Duloxetine HCl Exporters Duloxetine HCl exporters FDA Duloxetine HCl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Duloxetine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Duloxetine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Duloxetine Hydrochloride active pharmaceutical ingredients Duloxetine Hydrochloride committee active pharmaceutical ingredients manufacturer Duloxetine Hydrochloride Active Pharmaceutical Ingredients manufacturer Duloxetine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Duloxetine HCl, Duloxetine HCl manufacturer India, Duloxetine HCl product, Duloxetine HCl products, Api preparation, Certificate of Analysis API manufacturer product, Duloxetine HCl anti ulcer product, Certificate of Origin COA Duloxetine HCl COS Duloxetine HCl, pharmaceutical generic, pharmaceutical drug, medical, Duloxetine HCl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Duloxetine HCl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Duloxetine HCl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Duloxetine HCl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Duloxetine HCl ingredients, api, HIV Duloxetine HCl, tablets, capsules, syrup & protein Duloxetine HCl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Duloxetine HCl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Duloxetine HCl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

capsule





























 









 

 

HOME >> Pharmaceuticals API List 1 >> Duloxetine Hcl >> Side Effects

Duloxetine HCl CAS number 136434-34-9

SIDE EFFECTS
Duloxetine HCl CAS number 136434-34-9

Side effects cannot be anticipated. If any develop or change in intensity, tell your doctor as soon as possible. Only your doctor can determine if it is safe to continue using Duloxetine HCl.

Side effects may include:
Appetite changes, constipation, diarrhea, dizziness, dry mouth, fatigue, headache, insomnia, nausea, sexual difficulties, sleepiness, sweating, tremor, urinary difficulties, vomiting, weakness

Cardiovascular

Hot flush (3%); palpitations (2%); MI (0.1% to 1%); hypertensive crisis, supraventricular arrhythmia

CNS
Somnolence (21%); headache (20%); dizziness (17%); insomnia (16%); fatigue (15%); decreased appetite (11%); asthenia (8%); agitation (6%); tremor (5%); decreased libido (4%); abnormal dreams, anxiety, dysgeusia, migraine, pyrexia, sleep disorder (3%); yawning (2%); hypoesthesia, lethargy, vertigo (at least 1%); aggression, anger, extrapyramidal disorder, hallucinations (postmarketing).

Dermatologic
Hyperhidrosis (8%); rash (4%); pruritus (3%); erythema multiforme, Stevens-Johnson syndrome, urticaria

EENT
Nasopharyngitis (9%); pharyngolaryngeal pain (6%); blurred vision (3%); glaucoma, tinnitus
GI
Nausea (30%); dry mouth (18%); constipation (15%); diarrhea (13%); vomiting (6%); dyspepsia (5%); loose stools (3%); flatulence (at least 1%).

Genitourinary
Erectile dysfunction, pollakiuria (5%); ejaculation disorder (4%); abnormal orgasm, delayed ejaculation (3%); penis disorder (2%); anorgasmia (at least 1%).

Hypersensitivity
Anaphylactic reaction, angioneurotic edema, hypersensitivity

Metabolic-Nutritional
Anorexia (5%); decreased weight, increased weight (2%); hyperglycemia

Musculoskeletal
Muscle cramps, musculoskeletal pain (5%); muscle spasm, myalgia (4%); trismus

Respiratory
Upper respiratory tract infection (7%); cough (6%).

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS >>
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Duloxetine HCl

More Api at Taj Pharmaceuticals Ltd.

Alfuzosin

Oseltamivir Phosphate

 Amlodipine Besylate

Aripiprazole

Atorvastatin Calcium

Candesartan Cilaxetil

Cefdinir

Cetirizine Dihydrochloride

Ciprofloxacin HCl

Dextromethorphan Base

Diltiazem HCl

Domperidone Base

Domperidone Maleate

Doxazosin Mesylate

 Duloxetine HCl

Dutasteride

Enalapril Maleate

Esomeprazole Magnesium

Famotidine

Fexofenadine HCl

Fluconazole

Fluoxetine HCl

Galantamine HBr

Ibuprofen

Caffeine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.